Syneos Health strives to operate as a responsible corporate citizen of the global community. Management believes that socially responsible behavior provides long term value to our clients, employees, shareholders and the communities in which we live and work and is necessary for both business sustainability and growth.
We are involved in the drug development process. Our role is important and we take our responsibilities very seriously to ensure our business operations are conducted in an ethical manner and in accordance with industry standards and all applicable laws and regulations. Our corporate citizenship approach supports our mission and values and consists of integrated policies and practices for ethical conduct, regulatory compliance, internal controls, risk assessment and prevention, continual improvement and communication. It shapes how we conduct business.
Our vision is to be recognized as the best-in-class partner for drug development services, and to achieve it, we operate within the industry's highest medical, scientific, and regulatory standards, with uncompromising integrity and ethics, and respect for employees, clinical trial participants, investigators, suppliers, and the community. Specific corporate policies govern our approach to ethical behavior, quality, health and safety, environmental responsibility, supplier management, and global human resources.